-transparent.png){kind=logo}
We demonstrated previously tyrosine phosphorylation-dependent modulation of phospholipase C-gamma 1 (PLC-gamma 1) catalytic activity (Nishibe, S., Wahl, M. I., Hernandez-Sotomayor, S. M. T., Tonks, N. K., Rhee, S. G., and Carpenter, G. (1990) Science 250, 1253-1256). The increase in PLC-gamma 1 catalytic activity in A-431 cells occurs rapidly, with maximal activation 5 min after epidermal growth factor (EGF) stimulation. Certain other growth factors (fibroblast growth factor, platelet-derived growth factor) also stimulate PLC-gamma 1 catalytic activity, whereas insulin does not. A similar increase in PLC-gamma 1 specific activity (2-3-fold) was observed in both soluble (cytosol) and particulate (membrane) preparations from EGF-treated cells. Tyrosine-phosphorylated PLC-gamma 1 was detected in both cytosol and membrane fractions in lysates from EGF-treated A-431 cells, but the proportion of tyrosine-phosphorylated PLC-gamma 1 was higher in the cytosol (approximately 50%) than in the membrane (approximately 20%). Because a micellar concentration of the non-ionic detergent Triton X-100 allows detection of the tyrosine phosphorylation-dependent increase in PLC-gamma 1 catalytic activity in this assay, we evaluated the kinetic properties of PLC-gamma 1, immunoprecipitated from cytosol of control or EGF-treated cells, using substrate, phosphatidylinositol 4,5-bisphosphate (PtdIns 4,5-P2), solubilized in Triton X-100 at various molar ratios. The behavior of the control enzyme differed from the EGF-activated enzyme with respect to both Ks and Km. The control enzyme has a 7.5-fold higher Ks value than the activated enzyme (1.5 mM as compared with 0.22 mM). Activation by EGF is also a positive allosteric modifier of PLC-gamma 1-catalyzed PtdIns 4,5-P2 hydrolysis, i.e. the activated enzyme displayed apparent Michalis-Menton kinetics, with a Km of 0.6 mol fraction PtdIns 4,5-P2, whereas the control enzyme displayed sigmoidal kinetics with respect to PtdIns 4,5-P2 hydrolysis. At low substrate mol fractions (e.g. 0.07), the reaction velocity of the control enzyme was 4-fold lower than the activated enzyme. However, at a high substrate mol fraction (e.g. 0.33), the estimated maximal reaction velocities (Vmax) for both forms of PLC-gamma 1 were equivalent. PLC-gamma 1 activity from both control and EGF-treated cells was stimulated by increasing nanomolar Ca2+ concentrations. Although the catalytic activity of PLC-gamma 1 from EGF-treated cells was greater than control PLC-gamma 1 at every Ca2+ concentration tested, the relative stimulation of activity was markedly greater at Ca2+ concentrations above approximately 300 nM.
M I Wahl, and
G A Jones, and
S Nishibe, and
S G Rhee, and
G Carpenter
July 1990,
Science (New York, N.Y.),
M I Wahl, and
G A Jones, and
S Nishibe, and
S G Rhee, and
G Carpenter
April 1991,
Molecular and cellular biology,
M I Wahl, and
G A Jones, and
S Nishibe, and
S G Rhee, and
G Carpenter
April 2014,
Cancer discovery,
M I Wahl, and
G A Jones, and
S Nishibe, and
S G Rhee, and
G Carpenter
January 1997,
Advances in experimental medicine and biology,
M I Wahl, and
G A Jones, and
S Nishibe, and
S G Rhee, and
G Carpenter
November 1990,
Science (New York, N.Y.),
M I Wahl, and
G A Jones, and
S Nishibe, and
S G Rhee, and
G Carpenter
December 1995,
Virology,
M I Wahl, and
G A Jones, and
S Nishibe, and
S G Rhee, and
G Carpenter
November 1994,
The Journal of biological chemistry,
M I Wahl, and
G A Jones, and
S Nishibe, and
S G Rhee, and
G Carpenter
September 1990,
Molecular and cellular biology,
M I Wahl, and
G A Jones, and
S Nishibe, and
S G Rhee, and
G Carpenter
February 1991,
The Journal of biological chemistry,
M I Wahl, and
G A Jones, and
S Nishibe, and
S G Rhee, and
G Carpenter
September 1992,
The Biochemical journal,
